- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske studier sponset av Peking University Cancer Hospital and Institute
Totalt 6863 resultater
-
Tianjin Medical University Cancer Institute and...UkjentIIIB/IIIC/IV LungekreftKina
-
Tianjin Medical University Cancer Institute and...UkjentKjemoterapi effekt | Mottakelighet, genetiskKina
-
Tianjin Medical University Cancer Institute and...UkjentTrippel negativ brystkreftKina
-
Tianjin Medical University Cancer Institute and...UkjentBukspyttkjertelkreft stadium IV | Bukspyttkjertelkreft stadium IIIKina
-
Tianjin Medical University Cancer Institute and...UkjentStadium III Esophageal Cancer | Stadium II SpiserørskreftKina
-
Tianjin Medical University Cancer Institute and...UkjentTykktarmskreft LevermetastaseKina
-
Tianjin Medical University Cancer Institute and...UkjentDifferensiert skjoldbruskkarsinomKina
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...UkjentNeoplasmer i leverenKina
-
Tianjin Medical University Cancer Institute and...UkjentMetastatisk kreft i bukspyttkjertelen
-
Tianjin Medical University Cancer Institute and...UkjentIkke-småcellet lungekreftKina
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...UkjentMetastatisk nyrecellekarsinom
-
Tianjin Medical University Cancer Institute and...FullførtEffekt og optimal dosevalg av intranasal deksmedetomidin under brystklumpektomi under lokalbedøvelseIntranasal Dexmedetomidin Brystkreft Lokalbedøvelse
-
Tianjin Medical University Cancer Institute and...UkjentMetastatisk brystkreftKina
-
Tianjin Medical University Cancer Institute and...UkjentMetastatisk brystkreftKina
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...Ukjent
-
Tianjin Medical University Cancer Institute and...FullførtIkke småcellet lungekreftKina
-
Jun ZhuPeking University First Hospital; Tianjin Medical University Cancer Hospital og andre samarbeidspartnereRekruttering
-
Qilu Pharmaceutical Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Chinese... og andre samarbeidspartnereHar ikke rekruttert ennå
-
Beijing Immunochina Medical Science & Technology...Peking University Cancer Hospital & InstituteUkjentNon Hodgkin lymfomKina
-
Cancer Institute and Hospital, Chinese Academy...Peking University First Hospital; Shanxi Province Cancer Hospital; 307 Hospital... og andre samarbeidspartnereUkjentLungekreft | Kreftsmerter
-
Cancer Institute and Hospital, Chinese Academy...Zhejiang Cancer Hospital; General Hospital of Chinese Armed Police Forces; Peking University Third Hospital og andre samarbeidspartnereUkjent
-
Beijing Friendship HospitalPeking University People's Hospital; Peking Union Medical College Hospital og andre samarbeidspartnereRekrutteringEndetarmskreft | Tykktarmskreft | Prospektive studierKina
-
Jiangsu HengRui Medicine Co., Ltd.307 Hospital of PLA; Peking University Cancer Hospital & InstituteFullførtAvanserte solide maligniteterKina
-
Sichuan Cancer Hospital and Research InstituteHar ikke rekruttert ennåLungekreft | Lungeisolasjon
-
Sichuan Cancer Hospital and Research InstituteHar ikke rekruttert ennåPostoperativ lungebetennelse | Postoperativ pulmonal atelektase | Postoperativt lungeødem
-
Sichuan Cancer Hospital and Research InstituteHar ikke rekruttert ennå
-
Sichuan Cancer Hospital and Research InstituteRekruttering
-
Sichuan Cancer Hospital and Research InstituteHar ikke rekruttert ennå
-
Sichuan Cancer Hospital and Research InstituteRekrutteringEsophageal plateepitelkarsinomKina
-
Sichuan Cancer Hospital and Research InstituteRekruttering
-
Sichuan Cancer Hospital and Research InstituteRekrutteringLeversykdommer | Neoplasmer i fordøyelsessystemet | Neoplasmer i leveren | Hepatocellulært karsinom | Antineoplastiske midler | Molekylære mekanismer for farmakologisk virkning | Proteinkinasehemmere | SorafenibKina
-
Sichuan Cancer Hospital and Research InstituteAktiv, ikke rekrutterendeEsophageal plateepitelkarsinomKina
-
Sichuan Cancer Hospital and Research InstituteUkjentLungekreft | Småcellet lungekreft i omfattende stadiumKina
-
Sichuan Cancer Hospital and Research InstituteRekrutteringUtfall av røyker og drikker etter esofagektomiKina
-
Sichuan Cancer Hospital and Research InstituteRekruttering
-
Sichuan Cancer Hospital and Research InstituteRekruttering
-
Sichuan Cancer Hospital and Research InstituteHar ikke rekruttert ennå
-
Sichuan Cancer Hospital and Research InstituteHar ikke rekruttert ennå
-
Sichuan Cancer Hospital and Research InstituteRekrutteringIkke-småcellet lungekreft stadium III | Ikke-småcellet lungekreft stadium IIKina
-
Sichuan Cancer Hospital and Research InstituteHar ikke rekruttert ennåKirurgi | Neoadjuvant terapi | Esophageal plateepitelkarsinomKina
-
Sichuan Cancer Hospital and Research InstituteAktiv, ikke rekrutterendeNasofaryngealt karsinom | Kjemoradioterapi | PD-1-hemmereKina